Authors: Violette, SM Guan, W Bartlett, C Smith, JA Bardelay, C Antoine, E Rickles, RJ Mandine, E Van Schravendijk, MR Adams, SE Lynch, BA Shakespeare, WC Yang, M Jacobsen, VA Takeuchi, CS Macek, KJ Bohacek, RS Dalgarno, DC Weigele, M Lesuisse, D Sawyer, TK Baron, R

Citation: Sm. Violette et al., Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption, BONE, 28(1), 2001, pp. 54-64

Authors: Sundaramoorthi, R Siedem, C Vu, CB Dalgarno, DC Laird, EC Botfield, MC Combs, AB Adams, SE Yuan, RW Weigele, M Narula, SS

Citation: R. Sundaramoorthi et al., Selective inhibition of Src SH2 by a novel thiol-targeting tricarbonyl-modified inhibitor and mechanistic analysis by H-1/C-13 NMR spectroscopy, BIOORG MED, 11(13), 2001, pp. 1665-1669

Authors: Bohacek, RS Dalgarno, DC Hatada, M Jacobsen, VA Lynch, BA Macek, KJ Merry, T Metcalf, CA Narula, SS Sawyer, TK Shakespeare, WC Violette, SM Weigele, M

Citation: Rs. Bohacek et al., X-ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor, J MED CHEM, 44(5), 2001, pp. 660-663

Authors: Shakespeare, W Yang, M Bohacek, R Cerasoli, F Stebbins, K Sundaramoorthi, R Azimioara, M Vu, C Pradeepan, S Metcalf, C Haraldson, C Merry, T Dalgarno, D Narula, S Hatada, M Lu, XD van Schravendijk, MR Adams, S Violette, S Smith, J Guan, W Bartlett, C Herson, J Iuliucci, J Weigele, M Sawyer, T

Citation: W. Shakespeare et al., Structure-based design of an osteoclast-selective, nonpeptide Src homology2 inhibitor with in vivo antiresorptive activity, P NAS US, 97(17), 2000, pp. 9373-9378